Are you prepared for potential accelerated approval requirements?
Read more about the February 2020 position on RWE from ISPE.
Read the full article from UBC’s pharmacovigilance team in Drugs Real World Outcomes.
Listen to the full podcast from UBC with PharmaVOICE here.
Find out what access and adherence challenges patients will need to overcome in the evolving oncology market.
With continued investment in the RWE space, find out how to meet the needs of regulators, payers, and prescribers.
Discover why it is imperative to assess the potential of therapeutic proteins throughout the product lifecycle.
See more of the developments UBC’s evidence development and safety & risk management teams discussed.
February 4th is World Cancer Day, a global event on which we are united to spread awareness, education, and hope for this pervasive disease.
Find out more on the potential impact a product NDC change may have on your patient population.